Licensing of Radiopharmaceuticals in European Countries 1982

  • Knud Kristensen
Part of the Developments in Nuclear Medicine book series (DNUM, volume 4)


Licensing of individual pharmaceuticals has been used for many years as a mean of securing efficacy and safety of such products. During the last ten years a number of countries have introduced legislation in the field of radiopharmaceuticals (radioactive material intended for use in medical diagnosis or therapy). In order to obtain an up-to-date survey of the situation in European countries on the requirements for a licensing of radiopharmaceuticals letters were sent to authorities and individuals in all European countries. The following very short summary was written based on the replies received, and on information supplied by individuals. In the annex a list of adresses of relevant national authorities is given. In most countries regulations with the purpose of radiation protection with regard to workers and patients have been in force for many years. Such regulations are not reviewed here.


German Democratic Republic Royal Decree Product License Individual Request Radioactive Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Martinus Nijhoff Publishers, Boston 1984

Authors and Affiliations

  • Knud Kristensen

There are no affiliations available

Personalised recommendations